Annual CFI
-$360.00 K
-$163.00 K-82.74%
31 March 2024
Summary:
Immunovant annual cash flow from investing activities is currently -$360.00 thousand, with the most recent change of -$163.00 thousand (-82.74%) on 31 March 2024. During the last 3 years, it has fallen by -$150.00 thousand (-71.43%). IMVT annual CFI is now -1061.29% below its all-time high of -$31.00 thousand, reached on 31 March 2020.IMVT Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$196.00 K
-$14.00 K-7.69%
30 September 2024
Summary:
Immunovant quarterly cash flow from investing activities is currently -$196.00 thousand, with the most recent change of -$14.00 thousand (-7.69%) on 30 September 2024. Over the past year, it has dropped by -$162.00 thousand (-476.47%).IMVT Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$659.00 K
-$162.00 K-32.60%
30 September 2024
Summary:
Immunovant TTM cash flow from investing activities is currently -$659.00 thousand, with the most recent change of -$162.00 thousand (-32.60%) on 30 September 2024. Over the past year, it has dropped by -$456.00 thousand (-224.63%). IMVT TTM CFI is now -1302.13% below its all-time high of -$47.00 thousand, reached on 30 June 2020.IMVT TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMVT Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -82.7% | -476.5% | -224.6% |
| 3 y3 years | -71.4% | -345.4% | -254.3% |
| 5 y5 years | - | -100.0% | +99.4% |
IMVT Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -82.7% | at low | -653.9% | at low | -254.3% | at low |
| 5 y | 5 years | -1061.3% | at low | at low | -1302.1% | +99.4% | |
| alltime | all time | -1061.3% | at low | <-9999.0% | +99.8% | -1302.1% | +99.4% |
Immunovant Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$196.00 K(+7.7%) | -$659.00 K(+32.6%) |
| June 2024 | - | -$182.00 K(+21.3%) | -$497.00 K(+38.1%) |
| Mar 2024 | -$360.00 K(+82.7%) | -$150.00 K(+14.5%) | -$360.00 K(+52.5%) |
| Dec 2023 | - | -$131.00 K(+285.3%) | -$236.00 K(+16.3%) |
| Sept 2023 | - | -$34.00 K(-24.4%) | -$203.00 K(+1.5%) |
| June 2023 | - | -$45.00 K(+73.1%) | -$200.00 K(+1.5%) |
| Mar 2023 | -$197.00 K(-22.4%) | -$26.00 K(-73.5%) | -$197.00 K(-31.8%) |
| Dec 2022 | - | -$98.00 K(+216.1%) | -$289.00 K(+9.1%) |
| Sept 2022 | - | -$31.00 K(-26.2%) | -$265.00 K(-4.7%) |
| June 2022 | - | -$42.00 K(-64.4%) | -$278.00 K(+9.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | -$254.00 K(+21.0%) | -$118.00 K(+59.5%) | -$254.00 K(+10.0%) |
| Dec 2021 | - | -$74.00 K(+68.2%) | -$231.00 K(+24.2%) |
| Sept 2021 | - | -$44.00 K(+144.4%) | -$186.00 K(+2.8%) |
| June 2021 | - | -$18.00 K(-81.1%) | -$181.00 K(-13.8%) |
| Mar 2021 | -$210.00 K(+577.4%) | -$95.00 K(+227.6%) | -$210.00 K(+82.6%) |
| Dec 2020 | - | -$29.00 K(-25.6%) | -$115.00 K(+33.7%) |
| Sept 2020 | - | -$39.00 K(-17.0%) | -$86.00 K(+83.0%) |
| June 2020 | - | -$47.00 K(<-9900.0%) | -$47.00 K(-100.0%) |
| Mar 2020 | -$31.00 K | - | - |
| Sept 2019 | - | $0.00(-100.0%) | -$115.00 M(0.0%) |
| June 2019 | - | -$115.00 M | -$115.00 M |
FAQ
- What is Immunovant annual cash flow from investing activities?
- What is the all time high annual CFI for Immunovant?
- What is Immunovant annual CFI year-on-year change?
- What is Immunovant quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Immunovant?
- What is Immunovant quarterly CFI year-on-year change?
- What is Immunovant TTM cash flow from investing activities?
- What is the all time high TTM CFI for Immunovant?
- What is Immunovant TTM CFI year-on-year change?
What is Immunovant annual cash flow from investing activities?
The current annual CFI of IMVT is -$360.00 K
What is the all time high annual CFI for Immunovant?
Immunovant all-time high annual cash flow from investing activities is -$31.00 K
What is Immunovant annual CFI year-on-year change?
Over the past year, IMVT annual cash flow from investing activities has changed by -$163.00 K (-82.74%)
What is Immunovant quarterly cash flow from investing activities?
The current quarterly CFI of IMVT is -$196.00 K
What is the all time high quarterly CFI for Immunovant?
Immunovant all-time high quarterly cash flow from investing activities is $0.00
What is Immunovant quarterly CFI year-on-year change?
Over the past year, IMVT quarterly cash flow from investing activities has changed by -$162.00 K (-476.47%)
What is Immunovant TTM cash flow from investing activities?
The current TTM CFI of IMVT is -$659.00 K
What is the all time high TTM CFI for Immunovant?
Immunovant all-time high TTM cash flow from investing activities is -$47.00 K
What is Immunovant TTM CFI year-on-year change?
Over the past year, IMVT TTM cash flow from investing activities has changed by -$456.00 K (-224.63%)